Integra LifeSciences Mergers & Acquisitions

Integra LifeSciences M&A Summary

Integra LifeSciences has acquired 45 companies, including 3 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 3 assets.

Integra LifeSciences’ largest acquisition to date was in 2017, when it acquired Johnson & Johnson - Codman Neurosurgery Business for $1.0B. It’s largest disclosed sale occurred in 2020, when it sold Integra LifeSciences Holdings - Extremity Orthopaedics Business to Smith & Nephew for $240M. Integra LifeSciences has acquired in 13 different US states, and 7 countries. The Company’s most targeted sectors include medical products (85%) and distribution (7%).

M&A Summary

  • M&A Total Activity48
    • M&A Buy Activity45
    • M&A Sell Activity3
  • Total Sectors Invested 5
  • Total Countries Invested 7
  • M&A Buy/Sell Connections 15

Integra LifeSciences

Integra LifeSciences Holdings Corp.

1100 Campus Road,
Princeton, New Jersey 08540
United States,
(609) 275-0500
www.integralife.com

All (48) Buy (45) Sell (3)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2023-12-13 Acclarent · Medical Products
Menlo Park, California · www.acclarent.com

Acclarent is a medical device company dedicated to the development of innovative devices providing new technologies to further meet the needs of ENT patients. It has developed the Balloon Sinuplasty system: a novel, endoscopic, catheter-based technology used by surgeons for sinusitis patients. Acclarent was formed in 2004 and is based in Menlo Park, California.

275 Divestiture

Integra LifeSciences
Advisors: Goldman Sachs , Morgan Lewis

Ethicon Endo-Surgery, Inc.


Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.